Intrinsic Value of S&P & Nasdaq Contact Us

AdaptHealth Corp. AHCO NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
42/100
1/7 Pass
SharesGrow Intrinsic Value
$83.36
+559%
Analyst Price Target
$12.50
-1.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

AdaptHealth Corp. (AHCO) has a negative trailing P/E of -22.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 12.8 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -4.42%, forward earnings yield 7.84%. PEG 1.10.

Criteria proven by this page:

  • VALUE (64/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Forward P/E 12.8 — analysts expect a return to profitability with estimated EPS of $0.99 for FY2026.
  • PEG Ratio 1.10 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield -4.42% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 7.84% as earnings recover.
  • Analyst consensus target $12.50 (-1.2% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 42/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
42/100
SG Score
View full scorecard →
VALUE
64/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
59/100
Analyst consensus
→ Forecast
~
PAST
50/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
46/100
→ Income
GROWTH
30/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — AHCO

Valuation Multiples
P/E (TTM)-22.6
Forward P/E12.8
PEG Ratio1.10
Forward PEG1.10
P/B Ratio1.09
P/S Ratio0.58
EV/EBITDA7.1
Per Share Data
EPS (TTM)$-0.54
Forward EPS (Est.)$0.99
Book Value / Share$11.27
Revenue / Share$20.96
FCF / Share$1.62
Yields & Fair Value
Earnings Yield-4.42%
Forward Earnings Yield7.84%
Dividend Yield0.00%
SharesGrow IV$83.36 (+559%)
Analyst Target$12.50 (-1.2%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -79.9 0.00 0.00 1.74 -
2017 -437,409.8 4,374.90 12,470.69 1.57 -
2018 147.3 0.00 1.25 0.89 -
2019 -37.2 -0.24 -20.47 1.50 31.46%
2020 -12.2 0.01 5.56 1.87 -
2021 19.8 -0.10 1.50 1.26 -
2022 37.2 -0.69 1.20 0.87 -
2023 -1.4 0.00 0.67 0.31 -
2024 14.1 -0.13 0.81 0.39 -
2025 -19.0 0.10 0.89 0.41 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.12 $174.32M $-3.79M -2.2%
2017 $0.00 $192.56M $-693.00 -0%
2018 $0.07 $345.28M $2.09M 0.6%
2019 $0.54 $529.64M $12.24M 2.3%
2020 $-1.12 $1.06B $-58.72M -5.6%
2021 $0.67 $2.45B $156.18M 6.4%
2022 $0.50 $2.97B $69.32M 2.3%
2023 $-5.31 $3.2B $-678.9M -21.2%
2024 $0.61 $3.26B $90.42M 2.8%
2025 $-0.52 $3.24B $-70.79M -2.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.99 $0.96 – $1.01 $3.47B $3.45B – $3.49B 4
2027 $1.24 $1.12 – $1.36 $3.71B $3.67B – $3.74B 3
2028 $1.22 $0.89 – $1.70 $3.91B $3.91B – $3.91B 3
2029 $1.34 $1.32 – $1.36 $5.51B $5.46B – $5.56B 1
2030 $1.54 $1.52 – $1.56 $6.29B $6.23B – $6.35B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message